Familial Cancer Syndromes (5) Flashcards
Penetrance
Percentage with a gene change who develop the condition - modified by genetic variations/environmental factors
Gatekeepers
Directly regulate tumour growth: monitor and control cell division and death, preventing accumulation of mutations
Caretakers
Improve genomic stability e.g. repair of mutations/carcinogen metabolism
Landscapers
Control the surrounding stromal environment
Tumour suppressor genes
Protect cells from becoming cancerous, loss of function increases the risk of cancer e.g. APC, BRAC1/2, TP53, Rb
Oncogenes
Regulate cell growth and differentiation, gain of function/activating mutations increase the risk of cancer e.g. growth and signal transduction factors, RET gene
Knudsen’s two hit hypothesis
- Sporadic - two hits required in single cell (recessive)
- Inherited - one additional hit required in a single cell (autosomal dominant)
Most cancer syndromes are autosomal..
Dominant
Cancer syndromes that are autosomal recessive
- MYH associated polyposis, Fanconi anaemia, Ataxia telangiectasia
- Appears to skip generations and may account for some sporadic cases
Mutation types
- Splice site mutations
- Large deletions and duplications
- Translocations
Sporadic cancer
- Onset at older age
- One cancer in individual
- Unaffected family members
- Cancers that are rarely genetic - cervix, lung
Familial cancer
- Onset at younger age
- Multiple primaries in individual
- Other family members affected
- Same type/genetically-related cancers
Most common type of cancers in children are
Brain tumours and haematological
Retinoblastoma
- Childhood ocular cancer
- Rb1 gene (tumour suppressor)
- Genetic cases - one mutation is present in germline
- Inherited cases occur at younger average age
- Bilateral cases almost always germline
How common is retinoblastoma?
Very rare - 1 in 15,000-30,000 live births
Are there other cancer risks with retinoblastoma?
Yes e.g. osteosarcoma
Familial Adenomatous Polyposis (FAP)
- Hundreds of bowel polyps/adenomas from teens onwards
- Colonoscopies, total colectomy late teens/early 20s
How risky is FAP for bowel cancer?
up to 100% by 40 if not treated, accounts for 1% of all bowel cancers
Features of FAP
CHRPE, desmoid tumours, osetomas
What gene is involved in FAP?
APC tumour suppressor gene
What inheritance is FAP?
Autosomal dominant inheritance
Hereditary Non-Polyposis Colorectal Cancer (HNPCC)
- Accounts for 2-3% of bowel cancers
- Polyps common, polyposis not
What does polyposis mean?
Numerous internal polyps
How risky is NHPCC for bowel cancer?
60-80% risk of bowel adenomas/cancer from mid 20s onwards
Other cancer risks involved with NHPCC
Endometrial, ovarian, stomach, GU
Genes involved in NHPCC
Mismatch repair genes, MLH1 (50%), MSH2 (40%), MSH6 (10%), PMS1/2 (rare)
What kind of inheritance is NHPCC?
Autosomal dominant
Amsterdam Criteria for NHPCC shows what?
Who is at high risk
Amsterdam Criteria for NHPCC
- One member diagnosed with colorectal cancer before age 50 years
- Two affected generations
- Three affected relatives, one of them a first-degree relative of the other two
- FAP should be excluded
- Tumours should be verified by pathologic examination
Benefits of colonoscopic screening in NHPCC
Remove polyps/early detection of cancer improving survival
How often should you do colonoscopic screening in NHPCC
Every 18-24 months from 25
NHPCC preventative surgery
Women may consider hysterectomy
BRCA 1 and 2
10% of breast cancers under 40
What kind of inheritance is BRCA 1 and 2?
Autosomal dominant
BRCA 1 and 2 common in..
Jewish
Increased risk of which cancers with BRCA 1 and 2
Breast cancer (80%), ovarian (BRCA1 40%, BRCA2 15%), prostate, melanoma, male breast cancer
Options for BRCA 1 and BRCA 2 gene carriers
- Breast screening (annual MRI 30-50, annual mammography 35-40)
- Risk-reducing mastectomies, BSO
- Ovarian screening no use
Li Fraumeni Syndrome
- P53 mutations, rare
Li Fraumeni Syndrome inheritance..
Autosomal dominant
Li Fraumeni Syndrome risk of cancer
50% by age 40, close to 100% in lifetime
Li Fraumeni Syndrome, which cancers at risk of
Breast, sarcoma, brain, adrenocortical, leukaemia